Here's the biggest news you missed this weekend
Editors
Pause on Johnson & Johnson vaccine lifted in US
Johnson & Johnson's COVID-19 vaccine has been made available in parts of the U.S. again after an 11-day pause initiated when a rare blood clotting disorder was associated with the shot. The Food and Drug Administration and Centers for Disease Control and Prevention determined the benefits of the J&J vaccine outweighed the risks of keeping it off the market. Out of nearly 8 million who received the vaccine, 15 people have developed the condition and three have died. Moving forward, everyone who receives the shot should receive an information sheet mentioning the rare clotting problem and the symptoms to look out for, officials said. California and New York were among states administering the Johnson & Johnson COVID vaccine Sunday after their governors signed off on resuming use of the one-dose shot. Arizona, Colorado, Connecticut, Indiana, Louisiana, Maine, Massachusetts, Michigan, Missouri, Nevada, Tennessee, Texas and Virginia also have given the green light to the J&J vaccine.